Evaluation of Congenital Cytomegalovirus Infection in Pregnant Women Admitted to a University Hospital in Istanbul.
Evrim OzdemirTugba Sarac SivrikozKutay SarsarDilruba TureliMustafa OnelMehmet DemirciGizem YaparEray YurtsevenRecep HasAli AgacfidanHayriye Kırkoyun UysalPublished in: Viruses (2024)
Cytomegalovirus (CMV) can cause serious complications in immunocompromised individuals and fetuses with congenital infections. These can include neurodevelopmental impairments and congenital abnormalities in newborns. This paper emphasizes the importance of concurrently evaluating ultrasonography findings and laboratory parameters in diagnosing congenital CMV infection. To examine the prenatal characteristics of CMV DNA-positive patients, we assessed serum and amniotic fluid from 141 pregnant women aged 19-45 years, each with fetal anomalies. ELISA and PCR tests, conducted in response to these amniocentesis findings, were performed at an average gestational age of 25 weeks. Serological tests revealed that all 141 women were CMV IgG-positive, and 2 (1.41%) had low-avidity CMV IgG, suggesting a recent infection. CMV DNA was detected in 17 (12.05%) amniotic fluid samples using quantitative PCR. Of these, 82% exhibited central nervous system abnormalities. Given that most infections in pregnant women are undetectable and indicators non-specific, diagnosing primary CMV in pregnant women using clinical findings alone is challenging. We contend that serological tests should not be the sole means of diagnosing congenital CMV infection during pregnancy.
Keyphrases
- pregnant women
- gestational age
- pregnancy outcomes
- birth weight
- circulating tumor
- preterm birth
- newly diagnosed
- end stage renal disease
- ejection fraction
- type diabetes
- single molecule
- body mass index
- prognostic factors
- magnetic resonance
- metabolic syndrome
- preterm infants
- high resolution
- polycystic ovary syndrome
- acute respiratory distress syndrome
- cord blood
- nucleic acid
- extracorporeal membrane oxygenation